ICD-10 Coding for T-Cell Lymphoma(C84.4, C84.7, C84.7R)
Explore detailed ICD-10 coding guidelines for T-cell lymphoma, including cutaneous and CD30+ subtypes. Learn about documentation requirements and coding pitfalls.
Complete code families applicable to T-Cell Lymphoma
Compare key differences between these codes to ensure accurate selection
| Code | Description | When to Use | Key Documentation |
|---|---|---|---|
| C84.A | Cutaneous T-cell lymphoma, unspecified | Use when cutaneous T-cell lymphoma is diagnosed without further subtype specification. |
|
| C86.6 | Primary cutaneous CD30+ T-cell proliferations | Use when CD30+ cutaneous T-cell lymphoma is confirmed. |
|
Clinical Decision Support
Always review the patient's clinical documentation thoroughly. When in doubt, choose the more specific code and ensure documentation supports it.
Key Information
Essential facts and insights aboutT-Cell Lymphoma
Alternative codes to consider when ruling out similar conditions
Documentation & Coding Risks
Avoid these common issues when documenting T-Cell Lymphoma.
Failing to document CD30 status for cutaneous lymphomas.
Impact
Clinical: Misclassification of lymphoma subtype., Regulatory: Non-compliance with coding standards., Financial: Potential for claim denials.
Mitigation
Ensure pathology reports include CD30 status., Train staff on documentation requirements.
Using unspecified codes like C84.A0 without subtype documentation.
Impact
Reimbursement: May lead to claim denials or reduced reimbursement., Compliance: Non-compliance with coding guidelines., Data Quality: Impacts accuracy of clinical data.
Mitigation
Ensure documentation specifies subtype or CD30 status.
Unspecified coding
Impact
Use of unspecified codes without supporting documentation.
Mitigation
Ensure detailed documentation of lymphoma subtype and CD30 status.